Literature DB >> 31427368

Vascular Endothelial Receptor Tyrosine Phosphatase: Identification of Novel Substrates Related to Junctions and a Ternary Complex with EPHB4 and TIE2.

Hannes C A Drexler1, Matthias Vockel2,3, Christian Polaschegg2, Maike Frye2, Kevin Peters4, Dietmar Vestweber5.   

Abstract

Vascular endothelial protein tyrosine phosphatase (VE-PTP, PTPRB) is a receptor type phosphatase that is crucial for the regulation of endothelial junctions and blood vessel development. We and others have shown recently that VE-PTP regulates vascular integrity by dephosphorylating substrates that are key players in endothelial junction stability, such as the angiopoietin receptor TIE2, the endothelial adherens junction protein VE-cadherin and the vascular endothelial growth factor receptor VEGFR2. Here, we have systematically searched for novel substrates of VE-PTP in endothelial cells by utilizing two approaches. First, we studied changes in the endothelial phosphoproteome on exposing cells to a highly VE-PTP-specific phosphatase inhibitor followed by affinity isolation and mass-spectrometric analysis of phosphorylated proteins by phosphotyrosine-specific antibodies. Second, we used a substrate trapping mutant of VE-PTP to pull down phosphorylated substrates in combination with SILAC-based quantitative mass spectrometry measurements. We identified a set of substrate candidates of VE-PTP, of which a remarkably large fraction (29%) is related to cell junctions. Several of those were found in both screens and displayed very high connectivity in predicted functional interaction networks. The receptor protein tyrosine kinase EPHB4 was the most prominently phosphorylated protein on VE-PTP inhibition among those VE-PTP targets that were identified by both proteomic approaches. Further analysis revealed that EPHB4 forms a ternary complex with VE-PTP and TIE2 in endothelial cells. VE-PTP controls the phosphorylation of each of these two tyrosine kinase receptors. Despite their simultaneous presence in a ternary complex, stimulating each of the receptors with their own specific ligand did not cross-activate the respective partner receptor. Our systematic approach has led to the identification of novel substrates of VE-PTP, of which many are relevant for the control of cellular junctions further promoting the importance of VE-PTP as a key player of junctional signaling.
© 2019 Drexler et al.

Entities:  

Keywords:  cell adhesion; cell-cell interactions; immunoaffinity; phosphorylation; protein complex analysis; protein phosphatases; substrate identification; substrate trapping; tyrosine kinases

Mesh:

Substances:

Year:  2019        PMID: 31427368      PMCID: PMC6773558          DOI: 10.1074/mcp.RA119.001716

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  75 in total

Review 1.  Eph-ephrin bidirectional signaling in physiology and disease.

Authors:  Elena B Pasquale
Journal:  Cell       Date:  2008-04-04       Impact factor: 41.582

2.  EphB ligand, ephrinB2, suppresses the VEGF- and angiopoietin 1-induced Ras/mitogen-activated protein kinase pathway in venous endothelial cells.

Authors:  Injune Kim; Young Shin Ryu; Hee Jin Kwak; So Young Ahn; Jong-Lark Oh; George D Yancopoulos; Nicholas W Gale; Gou Young Koh
Journal:  FASEB J       Date:  2002-05-21       Impact factor: 5.191

3.  Treatment of diabetic macular edema with an inhibitor of vascular endothelial-protein tyrosine phosphatase that activates Tie2.

Authors:  Peter A Campochiaro; Raafay Sophie; Michael Tolentino; Daniel M Miller; David Browning; David S Boyer; Jeffrey S Heier; Laura Gambino; Barbara Withers; Mitchell Brigell; Kevin Peters
Journal:  Ophthalmology       Date:  2014-11-12       Impact factor: 12.079

Review 4.  Protein tyrosine phosphatase function: the substrate perspective.

Authors:  Tony Tiganis; Anton M Bennett
Journal:  Biochem J       Date:  2007-02-15       Impact factor: 3.857

5.  Identification of Fer tyrosine kinase localized on microtubules as a platelet endothelial cell adhesion molecule-1 phosphorylating kinase in vascular endothelial cells.

Authors:  Naoko Kogata; Michitaka Masuda; Yuji Kamioka; Akiko Yamagishi; Akira Endo; Masato Okada; Naoki Mochizuki
Journal:  Mol Biol Cell       Date:  2003-06-13       Impact factor: 4.138

6.  Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases.

Authors:  Ying-Nan P Chen; Matthew J LaMarche; Ho Man Chan; Peter Fekkes; Jorge Garcia-Fortanet; Michael G Acker; Brandon Antonakos; Christine Hiu-Tung Chen; Zhouliang Chen; Vesselina G Cooke; Jason R Dobson; Zhan Deng; Feng Fei; Brant Firestone; Michelle Fodor; Cary Fridrich; Hui Gao; Denise Grunenfelder; Huai-Xiang Hao; Jaison Jacob; Samuel Ho; Kathy Hsiao; Zhao B Kang; Rajesh Karki; Mitsunori Kato; Jay Larrow; Laura R La Bonte; Francois Lenoir; Gang Liu; Shumei Liu; Dyuti Majumdar; Matthew J Meyer; Mark Palermo; Lawrence Perez; Minying Pu; Edmund Price; Christopher Quinn; Subarna Shakya; Michael D Shultz; Joanna Slisz; Kavitha Venkatesan; Ping Wang; Markus Warmuth; Sarah Williams; Guizhi Yang; Jing Yuan; Ji-Hu Zhang; Ping Zhu; Timothy Ramsey; Nicholas J Keen; William R Sellers; Travis Stams; Pascal D Fortin
Journal:  Nature       Date:  2016-06-29       Impact factor: 49.962

7.  The tyrosine kinase Fer is a downstream target of the PLD-PA pathway that regulates cell migration.

Authors:  Toshiki Itoh; Junya Hasegawa; Kazuya Tsujita; Yasunori Kanaho; Tadaomi Takenawa
Journal:  Sci Signal       Date:  2009-09-08       Impact factor: 8.192

8.  Angiopoietin 2 stimulates migration and tube-like structure formation of murine brain capillary endothelial cells through c-Fes and c-Fyn.

Authors:  Yasushi Mochizuki; Takao Nakamura; Hiroshi Kanetake; Shigeru Kanda
Journal:  J Cell Sci       Date:  2002-01-01       Impact factor: 5.285

9.  ReCLIP (reversible cross-link immuno-precipitation): an efficient method for interrogation of labile protein complexes.

Authors:  Andrew L Smith; David B Friedman; Huapeng Yu; Robert H Carnahan; Albert B Reynolds
Journal:  PLoS One       Date:  2011-01-20       Impact factor: 3.240

10.  The tyrosine phosphatase SHP2 regulates recovery of endothelial adherens junctions through control of β-catenin phosphorylation.

Authors:  Ilse Timmerman; Mark Hoogenboezem; Anton M Bennett; Dirk Geerts; Peter L Hordijk; Jaap D van Buul
Journal:  Mol Biol Cell       Date:  2012-09-05       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.